Humanigen Inc (HGEN) Return on Investment ROI from the first quarter of 2023 to first quarter of 2022 and for the year 2023, average high and low, overall ranking from Mar 31 2023 to Mar 31 2022 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Humanigen Inc  (NASDAQ: HGEN)


Humanigen Inc's ROI from its first quarter of 2023 to the first quarter of 2022 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Humanigen Inc's ROI in the first quarter of 2023?
Due to the stockholders deficit and subsequent negative measured investments, it was not possible to calculate Humanigen Inc's return on investment (ROI) in its first quarter of 2023

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Mar 31 2023)
I. Quarter		 (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter
Y / Y Investment Change TTM - - - - -58.92 %
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions -48 -45 -50 -28 0
Return On Investment (TTM) - - - - -925.65 %
HGEN's Overall Ranking # # # # #
Seq. Investment Change TTM - - - - -35.35 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions -54 -71 -109 -152 -192

HGEN Company Profile >> Back to HGEN Roi Comparisons >> See Annual HGEN Return On Investment



Return On Investment HGEN's Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Investment Statistics
High Average Low
0 %
0 %
0 %
 







Financial Statements
Humanigen Inc's I. Quarter Investments $ -48 Millions HGEN's Balance sheet
Humanigen Inc's I. Quarter Income $ -4 Millions Quarterly HGEN's Income Statement
HGEN's Income by Division See HGEN's Income by Division


HGEN Annual Return On Investment (Dec 31 2022)
2022		 (Dec 31 2021)
2021		 (Dec 31 2020)
2020		 (Dec 31 2019)
2019		 (Dec 31 2018)
2018
Total Investments in Millions -45 2 48 -13 -7
Y / Y Investment Growth - -95.12 % - - -
Net Income in Millions -71 -237 -90 -10 -12
Y / Y Net Income Growth - - - - -
Annual Return On Investment - -10130.52 % -186.97 % - -


Annual Roi Comment


Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
HGEN's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for HGEN's Competitors
Subscribers only: Roi for Humanigen Inc's Suppliers
Subscribers only: Return On Investment for HGEN's Customers

Other Ratios
HGEN's Roa HGEN's Inventory Turnover Ratio HGEN's Growth Rates HGEN's Dividend Statistics
HGEN's Profitability Ratios HGEN's Asset Turnover Ratio HGEN's Dividend Growth
HGEN's Roe HGEN's Valuation Ratios HGEN's Financial Strength Ratios HGEN's Dividend Payout Ratio



Companies with similar Return On Investment at Mar 31 2023, within Healthcare Sector ROI
Inhibitor Therapeutics Inc   233.77 %
Theravance Biopharma inc   216.05 %
Ir med Inc   161.15 %
Talphera Inc   131.40 %
Molecular Templates Inc   130.08 %
Gyre Therapeutics Inc   101.97 %
Gamida Cell Ltd   88.50 %
Chimerix Inc   86.97 %
Tff Pharmaceuticals Inc  83.57 %
Avalo Therapeutics Inc   83.38 %
Revelation Biosciences Inc   67.96 %
Aptevo Therapeutics Inc   67.03 %
Voyager Therapeutics Inc   65.64 %
Opus Genetics Inc   65.61 %
Intercept Pharmaceuticals inc   63.41 %
Biomx Inc  60.93 %
Kiniksa Pharmaceuticals International Plc  56.13 %
Dariohealth Corp   54.64 %
Shockwave Medical Inc   48.20 %
Idexx Laboratories Inc  44.27 %
Fuse Medical Inc   43.08 %
Zymeworks Inc   42.67 %
Medpace Holdings Inc   40.11 %
Vaso Corporation  40.00 %
Arcturus Therapeutics Holdings Inc   38.17 %
Mettler toledo International Inc   35.59 %
Assertio Holdings inc   35.55 %
Harmony Biosciences Holdings inc   34.42 %
Catalyst Pharmaceuticals Inc   33.05 %
Nrc Health  31.34 %

Date modified: 2026-09-18T13:11:05+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.